Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results93

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results23

Views

Views
September 20252
October 20250
November 20251
December 20258
January 20266
February 20262
March 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Colombia2
Brazil2
Bolivia1
Congo1
Spain1
Senegal1
 

Top cities views

Views
Ashburn7
Brazzaville1
Bucaramanga1
Kolda1
La Paz1
Las Cabezas de San Juan1
Pouso Alegre1
Rio de Janeiro1